Meihua Medical Technologies Co., Ltd. (MHUA): Debts to Book Capitalization

Brandmark of meihuamed.com (MHUA)

Risks for MeihuaMed (MHUA) are tied to PRC government procurement and plastic prices. Low margins and stringent oversight pressure earnings, although the mass production of sterile products ensures supply stability. The current debt-to-book capitalization ratio demonstrates a support level, where 0.00 serves as the current parameter value, capturing the balance between borrowed funds and equity.

MHUA (Meihua Medical Technologies Co., Ltd.) Debt to Book Value history from 04/28/2023 to 12/20/2025
Original product of Meihua Medical Technologies

MeihuaMed (MHUA) is expanding the production of medical devices for the B2B segment, which requires strict control over its financing structure. This indicator compares total borrowings with the book value of equity to assess financial stability. By analyzing the current ratio of debt to book equity, an investor determines the extent to which expansion depends on credit resources. A decrease in this metric indicates growing business autonomy, while a stable ratio confirms the long-term preservation of assets.

Who MeihuaMed competes with

ISRG - Debts to Book Capitalization|Debt to Book Value Ratio danaher.com DHR|Debts to Book Capitalization BDX (Becton Dickinson)|STE - Debts to Net Assets|WST (West Pharmaceutical Services Inc) - Debts to Book Capitalization|Baxter Healthcare (BAX) - Debt to Book Value|MASI (Masimo Corporation) - Debts to Book Capitalization|Debts to Book Capitalization STVN|Debt to Book Capitalization Ratio Teleflex (TFX)|Debt to Book Capitalization Ratio Merit Medical Systems, Inc. MMSI|Debt to Book Value Envista Holdings Corp|Debt to Net Assets Ratio ICU Medical Inc. ICUI|Debts to Book Capitalization XRAY (DENTSPLY SIRONA Inc.)|LMAT: Debts to Net Assets|Debt to Book Capitalization Ratio AtriCure|STAA (STAAR Surgical Co.) - Debt to Book Value Ratio|NAGE: Debt to Book Capitalization Ratio|Debts to Net Assets ZimVie Corp (ZIMV)|Debt to Book Value AngioDynamics, Inc.|Debt to Book Capital CERS (cerus.com)|Debt to Book Capitalization Ratio Teknova|MGRM - Debt to Net Assets Ratio|Sharps Tech - Debt to Book Value|INFU: Debts to Book Capitalization|UTMD (Utah Medical Products) - Debt to Book Capitalization Ratio|KORU Medical (KRMD) - Debt to Book Value|Debts to Book Capitalization NYXH (Nyxoah)|Debts to Book Value MBOT|Debt to Book Capitalization Ratio Pro-Dex Corp PDEX|Debt to Book Value Ratio Zentek Corp ZTEK|Debt to Book Value Elutia Inc. (ELUT)|milestonescientific.com - Debt to Book Capital|Debt to Book Capitalization Ratio NXGL (NEXGEL)|RVP: Debts to Net Assets|HBIO (Harvard Bioscience, Inc.) - Debt to Book Capitalization Ratio|Femasys Corporation (FEMY) - Debt to Book Value|Debts to Book Capitalization POAI (Predictive Oncology Inc)|Debts to Book Value Callan JMB Corp|ATRI (Atrion) - Debts to Book Capitalization|Debts to Net Assets NeuroMetrix Inc (NURO)